Increasing Vascular Complications Depends on The Duration Disease of Having Been Diabetic Type 2

Zahraa Majid Ismail, Zyad Hussein Jawad, Ali Jasim Hammood

Abstract


Angiopathy is a major complication in (T2-DM), Endothelin-1 (ET-1) is considered the main vasoconstrictor (a mitogenic endothelium-derived peptide is mostly, produced by endothelial cells, as well by vascular smooth muscle cells, macrophages, and other cells). Previous studies suggested a link between T2-DM and ET-1. This paper aims to study the association between Endothelin-1 (ET-1) as a marker of endothelial dysfunction and the duration disease among patients with T2-DM, and to identify the effects of obesity and insulin resistance on elevated Endothelin level. The study includes 96 patients with T2-DM, aged between (45-70) years, (56.73 ± 9.14 years) is an average duration of having T2-DM (14.541± 11.462) years, and 96 healthy control subjects, aged (45-70) years, (56.42 ± 8.74 years). We show that the excess of ET-1 level was clearly linked with the duration of T2-DM, where the plasma Endothelin level was significantly changed among the studied groups (according to their duration) (11.607 ±0.783), (13.641± 0.729), (17.736 ± 3.409), (33.816 ± 12.902), (81.165 ± 35.404), and (156.783 ± 12.671) pg/mL respectively. Plasma ET-1 levels significant is positively correlated with T2-DM (R² = 0.9711, p ≤ 0.01), with obesity, insulin resistance, age, HOMO-IR, hypertension, and HDL level (p ≤ 0.05). As a conclusion, the plasma ET-1 level was significantly elevated as long as having been T2-DM.


Keywords


Endothelin (ET-1); diabetes type II (T2-DM); Insulin resistance (IR); Lipid profile.

Full Text:

PDF

References


Cecil, R.L.F., Goldman, L. and Schafer, A.I., 2012. Goldman's Cecil Medicine, Expert Consult Premium Edition--Enhanced Online Features and Print, Single Volume, 24: Goldman's Cecil Medicine (Vol. 1). Elsevier Health Sciences.

Akushevich, I., Yashkin, A.P., Kravchenko, J., Fang, F., Arbeev, K., Sloan, F. and Yashin, A.I., 2018. Identifying the causes of the changes in the prevalence patterns of diabetes in older US adults: A new trend partitioning approach. Journal of Diabetes and its Complications, 32(4), pp.362-367.

CrossRef | PubMed

Laakso, M. and Kuusisto, J., 2014. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nature Reviews Endocrinology, 10(5), p.293.

CrossRef | PubMed

Tanfin, Z., Robin, P., Oyeniran, C. and Breuiller-Fouché, M., 2011. Endothelin-1: physiological and pathological roles in myometrium. The international journal of biochemistry & cell biology, 43(3), pp.299-302.

CrossRef | PubMed

De Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T.D. and Vane, J.R., 1988. Pressor effects of circulating Endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proceedings of the National Academy of Sciences, 85(24), pp.9797-9800.

CrossRef | PubMed

Chatterjee, S., Khunti, K., Davies, M.J., 2017. Type 2 diabetes. Lancet 389: 2239e2251.

CrossRef

Clayton, D., Woo, V. and Yale, J.F., 2013. Hypoglycemia. Canadian journal of diabetes, 37, pp.S69-S71.

CrossRef | PubMed

Wagner, O.F., Christ, G., Wojta, J., Vierhapper, H., Parzer, S., Nowotny, P.J., Schneider, B., Waldh?usl, W. and Binder, B.R., 1992. Polar secretion of Endothelin-1 by cultured endothelial cells. Journal of Biological Chemistry, 267(23), pp.16066-16068.

Fagan, T.C. and Deedwania, P.C., 1998. The cardiovascular dysmetabolic syndrome. The American journal of medicine, 105(1), pp.77S-82S.

CrossRef

Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T., 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. nature, 332(6163), p.411.

CrossRef | PubMed

Barham, D. and Trinder, P., 1972. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97(1151), pp.142-145.

CrossRef | PubMed

Flier, J.S., Kahn, C.R. and Roth, J., 1979. Receptors, antireceptor antibodies and mechanisms of insulin resistance. New England Journal of Medicine, 300(8), pp.413-419.

CrossRef | PubMed

Association between Radiation Exposure and Endothelium-Dependent Vasodilation: Results from Clinical and Experimental Studies Zhu Z, et al, Journal of Vascular and Interventional Radiology, 2019.

Fossati, P. and Prencipe, L., 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical chemistry, 28(10), pp.2077-2080.

CrossRef | PubMed

Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W.F.P.C. and Fu, P.C., 1974. Enzymatic determination of total serum cholesterol. Clinical chemistry, 20(4), pp.470-475.

CrossRef | PubMed

Penttil?, I.M., Voutilainen, E., Laitinen, P. and Juutilainen, P., 1981. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scandinavian journal of clinical and laboratory investigation, 41(4), pp.353-360.

CrossRef | PubMed

Devasagayam, T.P., Tarachand, U., 1987. Decreased lipid peroxidation in the rat kidney during gestation. Biochem. Biophys. Res. Commun. 145, 134-138.

CrossRef

Ali, H., Rustam, R., Aprilia, D., Arizal, C., Gusadri, I.B. and Utami, P.R., 2019. Upregulation of SCUBE2 expression in dyslipidemic type 2 diabetes mellitus is associated with Endothelin-1. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(5), pp.2869-2872.

CrossRef | PubMed

Haak, T., Jungmann, E., Felber, A., Hillmann, U. and Usadel, K.H., 1992. Increased Plasma Levels of Endothelin in Diabetic Patients With Hypertension: An Alternative Viewpoint. American journal of hypertension, 5(3), pp.161-166.

CrossRef | PubMed

Gursel Aka, Suleyman Buyukberbera, Alper Sevinca , H., Mehmet Turka , Mehmet Atesa, Ramazan Saria, Haluk Savlia, Ahmet Ciglib., 2001. The relation between plasma Endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. Diabetes and Its Complications 15, 150 - 157.

CrossRef

Schneider, J.G., Tilly, N., Hierl, T., Sommer, U., Hamann, A., Dugi, K., Leidig-Bruckner, G. and Kasperk, C., 2002. Elevated plasma Endothelin-1 levels in diabetes mellitus. American journal of hypertension, 15(11), pp.967-972.

CrossRef

Güvener, N., Aytemir, K., Aks?yek, S. and Gedik, O., 1997. Plasma Endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease. Coronary artery disease, 8(5), pp.253-258.

CrossRef | PubMed

Bertello, P., Veglio, F., Pinna, G., Gurioli, L., Molino, P., Alban, S. and Chiandussi, L., 1994. Plasma Endothelin in NIDDM patients with and without complications. Diabetes Care, 17(6), pp.574-577.

CrossRef | PubMed

Veglio, F., Bertello, P., Pinna, G., Mulatero, P., Rossi, A., Gurioli, L., Panarelli, M. and Chiandussi, L., 1993. Plasma Endothelin in essential hypertension and diabetes mellitus. Journal of human hypertension, 7(4), pp.321-325.

Bertello, P., Veglio, F., Pinna, G., Gurioli, L., Molino, P., Alban, S. and Chiandussi, L., 1994. Plasma Endothelin in NIDDM patients with and without complications. Diabetes Care, 17(6), pp.574-577.

CrossRef | PubMed

Takahashi, K., Ghatei, M.A., Lam, H.C., O'halloran, D.J. and Bloom, S.R., 1990. Elevated plasma Endothelin in patients with diabetes mellitus. Diabetologia, 33(5), pp.306-310.

CrossRef | PubMed

Ahlborg, G., Shemyakin, A., B?hm, F., Gonon, A. and Pernow, J., 2007. Dual Endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease. Diabetes Care, 30(3), pp.591-596.

CrossRef | PubMed

Gaboury, C.L., Simonson, D.C., Seely, E.W., Hollenberg, N.K. and Williams, G.H., 1994. Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. The Journal of clinical investigation, 94(6), pp.2295-2300.

CrossRef | PubMed

Ishibashi, K.I., Imamura, T., Sharma, P.M., Huang, J., Ugi, S. and Olefsky, J.M., 2001. Chronic Endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. The Journal of clinical investigation, 107(9), pp.1193-1202.

CrossRef | PubMed

Shaw, S.G. and Boden, P.J., 2005. Insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for Endothelin-1 antagonists?. Current vascular pharmacology, 3(4), pp.359-363.

CrossRef | PubMed

Wheatcroft, S.B., Williams, I.L., Shah, A.M. and Kearney, M.T., 2003. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Medicine, 20(4), pp.255-268.

CrossRef | PubMed

Seligman, B.G., Biolo, A.N.D.R.E.I.A., Polanczyk, C.A., Gross, J.L. and Clausell, N., 2000. Increased plasma levels of Endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care, 23(9), pp.1395-1400.

CrossRef | PubMed

Cuchel, M. and Rader, D.J., 2006. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?. Circulation, 113(21), pp.2548-2555.

CrossRef | PubMed

Njajou, O.T., Kanaya, A.M., Holvoet, P., Connelly, S., Strotmeyer, E.S., Harris, T.B., Cummings, S.R. and Hsueh, W.C., 2009. Association between oxidized LDL, obesity and type 2 diabetes in a population?based cohort, the Health, Aging and Body Composition Study. Diabetes/metabolism research and reviews, 25(8), pp.733-739.

CrossRef | PubMed

Steinberg, D., 1997. Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry, 272(34), pp.20963-20966.

CrossRef | PubMed

Boulanger, C.M., Tanner, F.C., Bea, M.L., Hahn, A.W., Werner, A. and Lüscher, T.F., 1992. Oxidized low density lipoproteins induce mRNA expression and release of Endothelin from human and porcine endothelium. Circulation Research, 70(6), pp.1191-1197.

CrossRef | PubMed




DOI: http://dx.doi.org/10.23851/mjs.v31i3.848

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Al-Mustansiriyah Journal of Science

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Copyright (c) 2018 by Al-Mustansiriyah Journal of Science
ISSN: 1814-635X (Print), ISSN: 2521-3520 (online)